| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5700837 | European Journal of Surgical Oncology (EJSO) | 2017 | 10 Pages |
Abstract
major pathologic response is associated with a significant improvement in OS compared to no response or minor pathologic changes after neoadjuvant therapy in gastro-esophageal cancers. This should be considered a robust prognostic factor to guide postoperative treatment and follow-up.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
G. Tomasello, F. Petrelli, M. Ghidini, E. Pezzica, R. Passalacqua, F. Steccanella, L. Turati, G. Sgroi, S. Barni,